A prospective clinical post marketing users survey demonstrated that Taffix™, was able to reduce infection rate of SARS-CoV-2 virus after super spread event by at least 4 fold.
Nasus’s user survey was conducted in Bney Brak- a city that tops Israel’s list of COVID-19 infection and mortality. Members of a synagogue community were offered the use of Taffix and instructed to use it when approaching a highly populated environment. The survey was planned ahead of Rosh Hashana ( the Jewish new year) – an event that involved many hours spent in close proximity among prayers for at least 7 hours each day for 2 consecutive days and was defined as a super spread event. Users and non users among the synagogue community were followed up to 14 days after the event.
Rate of infection among non users was 10% ( 16/160,) while rate of infection among Taffix users was 2.4% ( 2/83 ITT, p=0.037) or 0% ( 0/81 PP p=0.002). At the same time period the general infection rate in the city of Bney Brak increased by some 60%,